About the journal
EJNMMI Research is an open-access journal published by SpringerOpen in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,690 EUR. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SpringerOpen
- ISSN
- 2191-219X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,690 EUR
- Articles in DOAJ
- 1182
- Declared review time
- 13 weeks
- Declared peer-review model
- other
- Official website
- https://www.ejnmmires.com/
Index listings
- DOAJ · 2012-06-11
- PUBMED · 2011-06-01
- Indexing
- DOAJ · PUBMED
- APC
- 2,690 EUR
- Declared review time (DOAJ)
- 13 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1182
Most recent article
last month
Average review time (journal-declared via DOAJ)
13weeks
Works in OpenAlex
1652
Last recorded publication year
2026
h-index
72
i10-index
878
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2012-06-11
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 89%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- European journal of nuclear medicine and molecular imaging research
- Source type
- journal
- NLM unique ID (PubMed)
- 101560946
- Society affiliations
- European Association of Nuclear Medicine
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Medical Imaging Techniques and Applications
- Medical Imaging Techniques and Applications
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Cardiac Imaging and Diagnostics
- Prostate Cancer Treatment and Research
Show all subjects (75)
- Prostate Cancer Treatment and Research
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Neuroendocrine Tumor Research Advances
- Radiomics and Machine Learning in Medical Imaging
- Prostate Cancer Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Lung Cancer Diagnosis and Treatment
- Advanced MRI Techniques and Applications
- Cardiac Imaging and Diagnostics
- Cardiac Imaging and Diagnostics
- Advanced MRI Techniques and Applications
- Advanced MRI Techniques and Applications
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Radiation Dose and Imaging
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Dementia and Cognitive Impairment Research
- MRI in cancer diagnosis
- Peptidase Inhibition and Analysis
- MRI in cancer diagnosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer, Hypoxia, and Metabolism
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer, Hypoxia, and Metabolism
- Neuroscience and Neuropharmacology Research
- Alzheimer's disease research and treatments
- Neuroscience and Neuropharmacology Research
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Hepatocellular Carcinoma Treatment and Prognosis
- Advanced Radiotherapy Techniques
- Parkinson's Disease Mechanisms and Treatments
- Advanced Radiotherapy Techniques
- Orthopedic Infections and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Medical Image Segmentation Techniques
- Radiation Dose and Imaging
- Radiation Dose and Imaging
- Neurotransmitter Receptor Influence on Behavior
- Orthopedic Infections and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Glioma Diagnosis and Treatment
- Neurotransmitter Receptor Influence on Behavior
- Monoclonal and Polyclonal Antibodies Research
- Neurological disorders and treatments
- Monoclonal and Polyclonal Antibodies Research
- Neurological disorders and treatments
- Advanced X-ray and CT Imaging
- Advanced X-ray and CT Imaging
- Lymphoma Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Lymphoma Diagnosis and Treatment
- Nanoplatforms for cancer theranostics
- Lymphoma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Neurotransmitter Receptor Influence on Behavior
- Optical Imaging and Spectroscopy Techniques
- Prostate Cancer Treatment and Research
- Effects of Radiation Exposure
- Neuroinflammation and Neurodegeneration Mechanisms
- Chemical Reactions and Isotopes
Keywords (DOAJ)
- nuclear medicine
- molecular imaging
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ